000 | 01170 a2200325 4500 | ||
---|---|---|---|
005 | 20250518091218.0 | ||
264 | 0 | _c20210309 | |
008 | 202103s 0 0 eng d | ||
022 | _a1365-2141 | ||
024 | 7 |
_a10.1111/bjh.16564 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aVarghese, Abraham M | |
245 | 0 | 0 |
_aCurrent pricing model for cancer drugs - is it 'Justum Pretium' for the developing world? Taking management of chronic lymphocytic leukaemia in India into consideration. _h[electronic resource] |
260 |
_bBritish journal of haematology _c09 2020 |
||
300 |
_ae292-e294 p. _bdigital |
||
500 | _aPublication Type: Letter | ||
650 | 0 | 4 | _aAged |
650 | 0 | 4 |
_aAntineoplastic Agents _xeconomics |
650 | 0 | 4 | _aCosts and Cost Analysis |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aIndia |
650 | 0 | 4 |
_aLeukemia, Lymphocytic, Chronic, B-Cell _xdrug therapy |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aModels, Economic |
700 | 1 | _aSood, Nitin | |
700 | 1 | _aDaniel, Sunitha M | |
773 | 0 |
_tBritish journal of haematology _gvol. 190 _gno. 5 _gp. e292-e294 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1111/bjh.16564 _zAvailable from publisher's website |
999 |
_c30720821 _d30720821 |